New Cardiff radiochemistry facility fully operational

Published: 22-Jun-2010

Quotient Bioresearch’s new facility in Cardiff has started shipments of radiolabelled products

Quotient Bioresearch’s state-of-the-art radiochemistry facility in Cardiff, UK is now fully operational and shipments of radiolabelled products have commenced.

The new facility, located close to Cardiff Bay, represents a significant investment by the Cambridge-based provider of early stage and specialist drug development services, and follows the company’s acquisition of Amersham Radiolabelling Services from GE Healthcare in June 2009.

The facility has been named “The Old Glassworks”, reflecting the origins of the site on which it was built. All staff have been successfully transferred from the former site operated by Amersham Radiolabelling Services to the new facility.

The facility will produce radiolabelled compounds for its pharmaceutical, biotechnology and agrochemical clients, offering an established bespoke service for the custom synthesis of carbon-14 and tritium labelled compounds. Quotient’s capabilities allow it to manufacture custom radiolabelled drugs for use in both pre-clinical and clinical settings.

An official opening ceremony will be held in September 2010.

You may also like